https://www.selleckchem.com/pr....oducts/Sunitinib-Mal
Carboplatin is a potent cytoreductive agent for a variety of solid tumors. However, when delivered systemically, clinical efficacy for the treatment of high grade gliomas is poor due to limited penetration across the blood-brain barrier (BB. Direct intracerebral (IC) convection-enhanced delivery (CED) of carboplatin has been used to bypass the BBB and successfully treat the F98 rat glioma. Based on these studies, we initiated a Phase I clinical trial. This Phase I clinical trial was conducted to establish the maximum
Curtir
Comentario
Compartilhar
